Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.
By:
Ross Levine MD Imprint: W B Saunders Co Ltd Country of Publication: United Kingdom Volume: 26-5 Dimensions:
Height: 236mm,
Width: 162mm,
Spine: 16mm
Weight: 400g ISBN:9781455749416 ISBN 10: 1455749419 Series:The Clinics: Internal Medicine Pages: 240 Publication Date:08 October 2012 Audience:
Professional and scholarly
,
Undergraduate
Format:Hardback Publisher's Status: Active
Human Oncology and Pathogenesis Program. Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.